.After antibody-drug conjugate (ADC) specialist Seagen was marketed to Pfizer in 2013 for a tremendo...
.On the heels of a period 3 gain that fell short to wow clients, Ironwood Pharmaceuticals is back al...
.Do not quit Monte Rosa Rehabs right now. The Boston-based biotech is actually enjoying after signin...
.Accept to recently's Chutes & Ladders, our roundup of substantial leadership hirings, firings an...
.Commemorating his provider's upsized going public (IPO), Septerna CEO Jeffrey Finer rang the positi...
.AbbVie has actually returned to the resource of its antipsychotic giant Vraylar looking for one mor...
.GenSight Biologics is actually full weeks off of running out of funds. Once more. The biotech simpl...
.Monopar Therapeutics is recuperating a drug from the dump of AstraZeneca's uncommon disease pipelin...
.Along with brand new data out on Arcus Biosciences' speculative HIF-2a prevention, one group of pro...
.After creating a genetics treatment partnership along with Dyno Therapeutics in 2020, Roche is actu...